FDA’s Jenkins On “Progressive Approval”: Don’t Lower The Efficacy Bar
Office of New Drugs director says a “weight of the evidence” standard will not provide reasonable assurance of drug efficacy and safety.
Office of New Drugs director says a “weight of the evidence” standard will not provide reasonable assurance of drug efficacy and safety.